These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32015233)

  • 1. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
    Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A
    Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
    Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
    J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.
    Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E
    J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
    Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
    Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.
    Fernandez-Cuesta L; Peifer M; Lu X; Sun R; Ozretić L; Seidal D; Zander T; Leenders F; George J; Müller C; Dahmen I; Pinther B; Bosco G; Konrad K; Altmüller J; Nürnberg P; Achter V; Lang U; Schneider PM; Bogus M; Soltermann A; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Ansén S; Stoelben E; Wright GM; Russell P; Wainer Z; Solomon B; Field JK; Hyde R; Davies MP; Heukamp LC; Petersen I; Perner S; Lovly C; Cappuzzo F; Travis WD; Wolf J; Vingron M; Brambilla E; Haas SA; Buettner R; Thomas RK
    Nat Commun; 2014 Mar; 5():3518. PubMed ID: 24670920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma.
    Zhang Y; Wang W; Hu Q; Liang Z; Zhou P; Tang Y; Jiang L
    BMC Cancer; 2022 Mar; 22(1):321. PubMed ID: 35331190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids.
    Swarts DR; Scarpa A; Corbo V; Van Criekinge W; van Engeland M; Gatti G; Henfling ME; Papotti M; Perren A; Ramaekers FC; Speel EJ; Volante M
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E374-8. PubMed ID: 24276465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.
    Derks JL; Leblay N; Lantuejoul S; Dingemans AC; Speel EM; Fernandez-Cuesta L
    J Thorac Oncol; 2018 Jun; 13(6):752-766. PubMed ID: 29454048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
    Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
    Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
    Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
    Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
    Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
    Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas.
    Gugger M; Burckhardt E; Kappeler A; Hirsiger H; Laissue JA; Mazzucchelli L
    J Pathol; 2002 Apr; 196(4):408-15. PubMed ID: 11920736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of developing neural transcription factors in lung carcinoid tumors.
    Endo T; Yazawa T; Shishido-Hara Y; Fujiwara M; Shimoyamada H; Ishii J; Sato H; Tachibana K; Takei H; Kondo H; Goya T; Endo S; Kamma H
    Pathol Int; 2014 Aug; 64(8):365-74. PubMed ID: 25143124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
    Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
    Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
    Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
    Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.
    Alcala N; Leblay N; Gabriel AAG; Mangiante L; Hervas D; Giffon T; Sertier AS; Ferrari A; Derks J; Ghantous A; Delhomme TM; Chabrier A; Cuenin C; Abedi-Ardekani B; Boland A; Olaso R; Meyer V; Altmuller J; Le Calvez-Kelm F; Durand G; Voegele C; Boyault S; Moonen L; Lemaitre N; Lorimier P; Toffart AC; Soltermann A; Clement JH; Saenger J; Field JK; Brevet M; Blanc-Fournier C; Galateau-Salle F; Le Stang N; Russell PA; Wright G; Sozzi G; Pastorino U; Lacomme S; Vignaud JM; Hofman V; Hofman P; Brustugun OT; Lund-Iversen M; Thomas de Montpreville V; Muscarella LA; Graziano P; Popper H; Stojsic J; Deleuze JF; Herceg Z; Viari A; Nuernberg P; Pelosi G; Dingemans AMC; Milione M; Roz L; Brcic L; Volante M; Papotti MG; Caux C; Sandoval J; Hernandez-Vargas H; Brambilla E; Speel EJM; Girard N; Lantuejoul S; McKay JD; Foll M; Fernandez-Cuesta L
    Nat Commun; 2019 Aug; 10(1):3407. PubMed ID: 31431620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors.
    Asiedu MK; Thomas CF; Dong J; Schulte SC; Khadka P; Sun Z; Kosari F; Jen J; Molina J; Vasmatzis G; Kuang R; Aubry MC; Yang P; Wigle DA
    Clin Cancer Res; 2018 Apr; 24(7):1691-1704. PubMed ID: 29351916
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic changes in the spectrum of neuroendocrine lung tumors.
    Onuki N; Wistuba II; Travis WD; Virmani AK; Yashima K; Brambilla E; Hasleton P; Gazdar AF
    Cancer; 1999 Feb; 85(3):600-7. PubMed ID: 10091733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.